This program offers additional funding for clinical trials if your project focuses on neurological products such as drugs and medical devices. With financial support to cover significant clinical trial costs, you can effectively transition your innovative idea to a market-ready product. This not only aids in commercialization but also means that your work can have a real impact on patient care and outcomes.

Securing this funding gives you a chance to partner with third-party investors. By having a strong Commercialization Plan, you can showcase how you’ll bring in more funding, thus enhancing your project's viability. It's a straightforward opportunity—without minimum revenue or employee requirements—allowing you to concentrate on what truly matters: advancing your research and educating potential stakeholders about your breakthrough solutions.

Applying for this program is a strategic step towards growth and innovation. If your project aligns with the goals set by the National Institute of Neurological Disorders and Stroke, this is a remarkable opportunity to access resources that can propel your business further along the path to success.

Type of Financing
This program offers grant funding. Grants are funds you receive that do not need to be repaid, making them an excellent option for supporting your clinical trials.

Repayment Terms & Eligible Expenses
There is no repayment required for the grant. However, it's important to have a clear Commercialization Plan that shows how you will secure independent third-party funding equal to or greater than the NINDS funds requested. Eligible expenses for the grant include costs related to clinical trials, such as evaluating drugs, biologics, medical devices, diagnostics, and therapies that align with the goals of the National Institute of Neurological Disorders and Stroke.

Usage Restrictions & Fees
Funds cannot be used for unrelated business activities or expenses not directly tied to the clinical trial projects. There are typically no fees associated with this program, ensuring that you can allocate all funds directly towards your research and development efforts.

• Business Type: Must be a small business concern (SBC).
• Previous Funding: Must have received previous NIH SBIR or STTR Phase II awards.
• Project Focus: Must focus on products related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS).
• Project Type: Must evaluate drugs, biologics, devices, diagnostics, or therapies (surgical, behavioral, rehabilitation).
• Commercialization Plan: Must submit a Commercialization Plan detailing any independent third-party investor funding.
• Independent Funding: Expected third-party funding must equal or exceed the NINDS funds requested during the project period.
• Location: Available to businesses across the country.
• Employees: No minimum or maximum employee requirements.
• Company Revenue: No minimum or maximum revenue qualifications.
• Legal Structure: Any legal structure is applicable.
• Profit Structure: Any profit structure is applicable.

Disqualifications: None specified in the context provided.

This program offers you additional funding for clinical trials if you have already received support from the NIH. It is specifically for projects that focus on neurological products, including drugs, devices, and therapies. The goal is to help you take your project further along the path to commercialization.

You can gain financial support to cover the costs of clinical trials, which can be significant. This can help you transition your business from an idea to a market-ready product, ultimately benefiting patients and your bottom line. To qualify, you will need a Commercialization Plan that outlines how you'll secure additional funding from third parties, matching or exceeding the funds you’re seeking.

As long as your project aligns with the objectives of the National Institute of Neurological Disorders and Stroke, this is a valuable opportunity to secure the resources you need to advance your clinical research. With funding available nationwide, you can explore potential partnerships and take your innovations to the next level.